Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Blood Specimen Collection | 4 | 2017 | 237 | 1.470 |
Why?
|
Phlebotomy | 7 | 2017 | 137 | 1.310 |
Why?
|
Troponin I | 12 | 2015 | 624 | 0.990 |
Why?
|
Creatine Kinase, MB Form | 2 | 2015 | 209 | 0.960 |
Why?
|
Diagnostic Tests, Routine | 4 | 2015 | 780 | 0.870 |
Why?
|
Clinical Laboratory Information Systems | 5 | 2017 | 107 | 0.860 |
Why?
|
Workflow | 7 | 2021 | 836 | 0.790 |
Why?
|
Automation, Laboratory | 1 | 2021 | 102 | 0.750 |
Why?
|
Drug Monitoring | 5 | 2013 | 948 | 0.680 |
Why?
|
Vancomycin | 2 | 2013 | 495 | 0.680 |
Why?
|
Myoglobin | 5 | 2005 | 159 | 0.620 |
Why?
|
Pulmonary Surfactants | 4 | 2004 | 159 | 0.550 |
Why?
|
Laboratories | 5 | 2021 | 459 | 0.500 |
Why?
|
Creatine Kinase | 7 | 2014 | 689 | 0.470 |
Why?
|
Chemistry, Clinical | 3 | 2007 | 64 | 0.440 |
Why?
|
Laboratories, Hospital | 7 | 2017 | 193 | 0.420 |
Why?
|
Patient Satisfaction | 3 | 2017 | 3416 | 0.400 |
Why?
|
Fetal Organ Maturity | 8 | 2004 | 83 | 0.400 |
Why?
|
Acute Coronary Syndrome | 2 | 2015 | 2333 | 0.390 |
Why?
|
Efficiency, Organizational | 3 | 2017 | 681 | 0.380 |
Why?
|
Blood Glucose | 4 | 2022 | 6220 | 0.370 |
Why?
|
Albumins | 6 | 2005 | 563 | 0.360 |
Why?
|
Myocardial Infarction | 13 | 2015 | 11661 | 0.360 |
Why?
|
Glucose | 1 | 2022 | 4304 | 0.350 |
Why?
|
Thrombolytic Therapy | 5 | 2005 | 2072 | 0.350 |
Why?
|
Amniotic Fluid | 5 | 2004 | 377 | 0.350 |
Why?
|
Respiratory Distress Syndrome, Newborn | 7 | 2006 | 217 | 0.350 |
Why?
|
Vascular Patency | 2 | 2005 | 889 | 0.340 |
Why?
|
Electronic Health Records | 4 | 2017 | 4565 | 0.300 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2009 | 385 | 0.300 |
Why?
|
Phosphatidylcholines | 3 | 2000 | 406 | 0.280 |
Why?
|
Pregnancy in Diabetics | 2 | 2000 | 187 | 0.270 |
Why?
|
Clinical Laboratory Techniques | 5 | 2012 | 740 | 0.260 |
Why?
|
Reference Standards | 2 | 2022 | 1004 | 0.250 |
Why?
|
Lung | 8 | 2004 | 9918 | 0.240 |
Why?
|
Urinalysis | 2 | 2018 | 349 | 0.230 |
Why?
|
Clinical Enzyme Tests | 2 | 1999 | 113 | 0.210 |
Why?
|
Pathology, Clinical | 3 | 2002 | 368 | 0.210 |
Why?
|
Angina, Unstable | 4 | 2000 | 917 | 0.210 |
Why?
|
Blood Glucose Self-Monitoring | 2 | 2022 | 450 | 0.200 |
Why?
|
Education, Medical | 1 | 2013 | 1714 | 0.200 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2002 | 215 | 0.180 |
Why?
|
Blood Coagulation Tests | 1 | 2021 | 262 | 0.180 |
Why?
|
Gestational Age | 7 | 2004 | 3520 | 0.180 |
Why?
|
Quality of Health Care | 2 | 2014 | 4286 | 0.180 |
Why?
|
Troponin | 3 | 2015 | 513 | 0.170 |
Why?
|
Unnecessary Procedures | 3 | 2003 | 415 | 0.170 |
Why?
|
Diagnostic Errors | 3 | 2016 | 1255 | 0.170 |
Why?
|
Personnel Staffing and Scheduling | 2 | 2014 | 494 | 0.170 |
Why?
|
Myocardium | 2 | 2007 | 4634 | 0.150 |
Why?
|
Hyperparathyroidism | 1 | 1999 | 336 | 0.150 |
Why?
|
Outpatients | 4 | 2017 | 1554 | 0.140 |
Why?
|
Chromatography, Liquid | 2 | 2018 | 967 | 0.140 |
Why?
|
Data Display | 1 | 1997 | 176 | 0.140 |
Why?
|
Blood Cell Count | 2 | 2017 | 396 | 0.140 |
Why?
|
Immunoassay | 3 | 2018 | 734 | 0.140 |
Why?
|
Humans | 74 | 2023 | 746839 | 0.140 |
Why?
|
Platelet Aggregation | 2 | 1991 | 789 | 0.140 |
Why?
|
Computers | 1 | 1999 | 594 | 0.130 |
Why?
|
Substance Abuse Detection | 1 | 2018 | 286 | 0.130 |
Why?
|
Hospital Charges | 1 | 1997 | 357 | 0.130 |
Why?
|
Pathology Department, Hospital | 1 | 2015 | 10 | 0.130 |
Why?
|
Hospital Information Systems | 2 | 2017 | 398 | 0.130 |
Why?
|
Blood Coagulation | 1 | 2021 | 1138 | 0.130 |
Why?
|
Utilization Review | 2 | 2015 | 382 | 0.120 |
Why?
|
Isoenzymes | 5 | 1999 | 1695 | 0.120 |
Why?
|
Tandem Mass Spectrometry | 2 | 2018 | 1165 | 0.120 |
Why?
|
Heart Diseases | 1 | 2007 | 2765 | 0.120 |
Why?
|
Point-of-Care Systems | 2 | 2022 | 1178 | 0.120 |
Why?
|
Tissue Plasminogen Activator | 1 | 1999 | 1152 | 0.110 |
Why?
|
Anti-Bacterial Agents | 1 | 2012 | 7215 | 0.110 |
Why?
|
Cost Control | 2 | 2015 | 624 | 0.110 |
Why?
|
Coronary Vessels | 1 | 2005 | 3073 | 0.110 |
Why?
|
Academic Medical Centers | 6 | 2017 | 2708 | 0.110 |
Why?
|
Sensitivity and Specificity | 10 | 2023 | 14543 | 0.110 |
Why?
|
Time Factors | 10 | 2017 | 39639 | 0.110 |
Why?
|
Hospitals, Teaching | 3 | 2012 | 1159 | 0.110 |
Why?
|
Models, Biological | 2 | 2002 | 9460 | 0.110 |
Why?
|
Time | 1 | 2013 | 540 | 0.100 |
Why?
|
Reference Values | 3 | 2014 | 4884 | 0.100 |
Why?
|
Myeloma Proteins | 1 | 2010 | 71 | 0.090 |
Why?
|
Predictive Value of Tests | 9 | 2007 | 15012 | 0.090 |
Why?
|
Renal Dialysis | 1 | 2000 | 1695 | 0.090 |
Why?
|
Preoperative Care | 1 | 1999 | 2223 | 0.090 |
Why?
|
Potassium | 1 | 2014 | 1313 | 0.090 |
Why?
|
Patient Identification Systems | 1 | 2010 | 76 | 0.090 |
Why?
|
Cost Savings | 2 | 2013 | 920 | 0.090 |
Why?
|
ROC Curve | 5 | 2006 | 3499 | 0.080 |
Why?
|
Costs and Cost Analysis | 1 | 2014 | 1660 | 0.080 |
Why?
|
Hospitals | 1 | 2022 | 3857 | 0.080 |
Why?
|
Evidence-Based Practice | 1 | 2012 | 492 | 0.080 |
Why?
|
Kidney Failure, Chronic | 1 | 2000 | 2452 | 0.070 |
Why?
|
Troponin T | 2 | 2015 | 751 | 0.070 |
Why?
|
Prostate-Specific Antigen | 3 | 2001 | 2511 | 0.070 |
Why?
|
Parathyroid Hormone | 2 | 2005 | 1782 | 0.070 |
Why?
|
Postmenopause | 1 | 1995 | 2462 | 0.070 |
Why?
|
Physical Exertion | 1 | 1988 | 658 | 0.070 |
Why?
|
Female | 29 | 2018 | 382565 | 0.060 |
Why?
|
Myocardial Ischemia | 2 | 2007 | 2142 | 0.060 |
Why?
|
Decision Support Systems, Clinical | 2 | 2006 | 1146 | 0.060 |
Why?
|
Inpatients | 2 | 2014 | 2517 | 0.060 |
Why?
|
Emergency Service, Hospital | 2 | 2015 | 7705 | 0.060 |
Why?
|
Phosphoproteins | 1 | 1993 | 2405 | 0.060 |
Why?
|
Medical Errors | 2 | 2010 | 1250 | 0.060 |
Why?
|
Boston | 6 | 2014 | 9213 | 0.060 |
Why?
|
Nurses | 1 | 2013 | 2441 | 0.060 |
Why?
|
Autopsy | 1 | 2007 | 995 | 0.060 |
Why?
|
Program Evaluation | 1 | 2012 | 2456 | 0.060 |
Why?
|
Male | 24 | 2015 | 351538 | 0.060 |
Why?
|
Middle Aged | 21 | 2014 | 214698 | 0.060 |
Why?
|
Parathyroid Neoplasms | 1 | 2005 | 240 | 0.060 |
Why?
|
Natriuretic Peptides | 1 | 2004 | 151 | 0.060 |
Why?
|
CD40 Ligand | 1 | 2005 | 487 | 0.060 |
Why?
|
Ambulatory Care | 1 | 2014 | 2731 | 0.050 |
Why?
|
Clinical Pharmacy Information Systems | 1 | 2003 | 101 | 0.050 |
Why?
|
Decision Making, Computer-Assisted | 1 | 2003 | 146 | 0.050 |
Why?
|
Aspirin | 2 | 1991 | 3288 | 0.050 |
Why?
|
Calcium | 1 | 1995 | 5656 | 0.050 |
Why?
|
Drug Therapy, Computer-Assisted | 1 | 2003 | 198 | 0.050 |
Why?
|
Medication Adherence | 1 | 2013 | 2113 | 0.050 |
Why?
|
Silicone Gels | 1 | 2001 | 39 | 0.050 |
Why?
|
Hospital Bed Capacity, 500 and over | 2 | 1997 | 114 | 0.050 |
Why?
|
Medical Order Entry Systems | 1 | 2006 | 517 | 0.050 |
Why?
|
Electrocardiography | 3 | 2005 | 6319 | 0.050 |
Why?
|
Aged | 16 | 2014 | 164457 | 0.040 |
Why?
|
Myocardial Reperfusion | 1 | 2001 | 345 | 0.040 |
Why?
|
Cryopreservation | 1 | 2005 | 700 | 0.040 |
Why?
|
Anticonvulsants | 2 | 2003 | 1875 | 0.040 |
Why?
|
Biopsy, Needle | 1 | 2005 | 1634 | 0.040 |
Why?
|
Reminder Systems | 1 | 2003 | 376 | 0.040 |
Why?
|
Hospital Communication Systems | 1 | 1999 | 48 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2023 | 967 | 0.040 |
Why?
|
Infant, Newborn | 7 | 2006 | 25765 | 0.040 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 1999 | 173 | 0.040 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2000 | 184 | 0.040 |
Why?
|
Oximetry | 1 | 2002 | 459 | 0.040 |
Why?
|
Pregnancy | 6 | 2004 | 29298 | 0.040 |
Why?
|
Twins | 1 | 2000 | 335 | 0.040 |
Why?
|
Up-Regulation | 1 | 2007 | 4118 | 0.040 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 2 | 2001 | 280 | 0.040 |
Why?
|
Paraproteinemias | 1 | 2001 | 243 | 0.040 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 1991 | 3118 | 0.040 |
Why?
|
Enoxaparin | 1 | 2000 | 382 | 0.040 |
Why?
|
Immunoglobulin M | 1 | 2023 | 1508 | 0.040 |
Why?
|
Digoxin | 1 | 1999 | 243 | 0.040 |
Why?
|
Regression Analysis | 4 | 2001 | 6337 | 0.040 |
Why?
|
Reagent Kits, Diagnostic | 2 | 2001 | 231 | 0.040 |
Why?
|
Chest Pain | 1 | 2005 | 1095 | 0.040 |
Why?
|
Therapy, Computer-Assisted | 1 | 1999 | 269 | 0.040 |
Why?
|
Microcirculation | 1 | 2002 | 1284 | 0.040 |
Why?
|
Breast Implants | 1 | 2001 | 398 | 0.040 |
Why?
|
Attitude to Computers | 1 | 2017 | 199 | 0.030 |
Why?
|
Ischemia | 1 | 2005 | 1860 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2018 | 955 | 0.030 |
Why?
|
Computer Systems | 1 | 1997 | 471 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2014 | 57622 | 0.030 |
Why?
|
Cardiotonic Agents | 1 | 1999 | 533 | 0.030 |
Why?
|
Tuberculosis, Urogenital | 1 | 1974 | 9 | 0.030 |
Why?
|
Prognosis | 6 | 2000 | 29078 | 0.030 |
Why?
|
Adenoma | 1 | 2005 | 2139 | 0.030 |
Why?
|
Surface-Active Agents | 1 | 1994 | 149 | 0.030 |
Why?
|
Interinstitutional Relations | 1 | 1995 | 239 | 0.030 |
Why?
|
Prospective Studies | 7 | 2015 | 53268 | 0.030 |
Why?
|
Radiology Department, Hospital | 1 | 1997 | 405 | 0.030 |
Why?
|
Hospitals, University | 1 | 1995 | 567 | 0.030 |
Why?
|
Clinical Protocols | 1 | 1999 | 1428 | 0.030 |
Why?
|
Medical Staff, Hospital | 1 | 1997 | 595 | 0.030 |
Why?
|
Morphine Derivatives | 1 | 2013 | 43 | 0.030 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2000 | 3333 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2012 | 78360 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 1999 | 12842 | 0.030 |
Why?
|
Casein Kinase II | 1 | 1993 | 123 | 0.030 |
Why?
|
Tramadol | 1 | 2013 | 52 | 0.030 |
Why?
|
Risk Assessment | 5 | 2004 | 23470 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2017 | 8906 | 0.030 |
Why?
|
Erythrocytes | 1 | 2002 | 2397 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2017 | 1093 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2010 | 5096 | 0.030 |
Why?
|
Respiration Disorders | 1 | 1996 | 368 | 0.030 |
Why?
|
Medical Records | 1 | 1998 | 1392 | 0.030 |
Why?
|
Phosphopeptides | 1 | 1993 | 242 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 1994 | 1636 | 0.030 |
Why?
|
Models, Statistical | 1 | 2006 | 5037 | 0.030 |
Why?
|
Microscopy | 1 | 2017 | 878 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2023 | 3074 | 0.020 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 1993 | 552 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 1999 | 1755 | 0.020 |
Why?
|
Capillaries | 1 | 1994 | 767 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2023 | 4481 | 0.020 |
Why?
|
Fibrinolytic Agents | 1 | 2000 | 2135 | 0.020 |
Why?
|
CHO Cells | 1 | 1993 | 1394 | 0.020 |
Why?
|
Reproducibility of Results | 3 | 2005 | 19825 | 0.020 |
Why?
|
Fentanyl | 1 | 2013 | 415 | 0.020 |
Why?
|
Cricetinae | 1 | 1993 | 2427 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1993 | 1553 | 0.020 |
Why?
|
Receptor, Insulin | 1 | 1993 | 834 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 1999 | 2655 | 0.020 |
Why?
|
Substrate Specificity | 1 | 1993 | 1782 | 0.020 |
Why?
|
Coronary Artery Disease | 1 | 2007 | 6456 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 1993 | 4188 | 0.020 |
Why?
|
Cattle | 1 | 1993 | 3840 | 0.020 |
Why?
|
Massachusetts | 2 | 1997 | 8613 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 1999 | 38800 | 0.020 |
Why?
|
Amino Acids | 1 | 1993 | 1703 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 1997 | 12021 | 0.020 |
Why?
|
Patient Selection | 1 | 1999 | 4197 | 0.020 |
Why?
|
Brain | 1 | 1993 | 26598 | 0.020 |
Why?
|
Capital Expenditures | 1 | 2006 | 28 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2015 | 7281 | 0.020 |
Why?
|
Ultrasonography | 1 | 1999 | 5902 | 0.020 |
Why?
|
Antitubercular Agents | 1 | 1974 | 1347 | 0.020 |
Why?
|
Quality Assurance, Health Care | 2 | 2012 | 2166 | 0.020 |
Why?
|
Specimen Handling | 1 | 2010 | 695 | 0.020 |
Why?
|
Risk | 3 | 2006 | 9522 | 0.020 |
Why?
|
Transfection | 1 | 1993 | 5789 | 0.020 |
Why?
|
Buprenorphine | 1 | 2013 | 647 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2011 | 2342 | 0.020 |
Why?
|
Critical Care | 1 | 1998 | 2664 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2004 | 15561 | 0.020 |
Why?
|
Survival Rate | 1 | 1999 | 12645 | 0.010 |
Why?
|
Frozen Sections | 1 | 2005 | 154 | 0.010 |
Why?
|
Investments | 1 | 2006 | 143 | 0.010 |
Why?
|
Logistic Models | 3 | 2006 | 13172 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 1994 | 2689 | 0.010 |
Why?
|
Pilot Projects | 1 | 1997 | 8380 | 0.010 |
Why?
|
Budgets | 1 | 2006 | 229 | 0.010 |
Why?
|
Odds Ratio | 2 | 2012 | 9600 | 0.010 |
Why?
|
Fluorescence Polarization | 1 | 2004 | 133 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 1993 | 6517 | 0.010 |
Why?
|
Atrial Natriuretic Factor | 1 | 2004 | 378 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2017 | 3837 | 0.010 |
Why?
|
Parathyroidectomy | 1 | 2005 | 240 | 0.010 |
Why?
|
Adult | 6 | 2000 | 215288 | 0.010 |
Why?
|
Health Planning Guidelines | 1 | 2003 | 154 | 0.010 |
Why?
|
Phosphorylation | 1 | 1993 | 8294 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 2018 | 4297 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2015 | 3550 | 0.010 |
Why?
|
Pharmacy Service, Hospital | 1 | 2003 | 135 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 1997 | 7942 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 1993 | 13513 | 0.010 |
Why?
|
alpha 1-Antichymotrypsin | 1 | 2001 | 19 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8444 | 0.010 |
Why?
|
Autoanalysis | 1 | 2001 | 71 | 0.010 |
Why?
|
Hospitalization | 2 | 1998 | 10342 | 0.010 |
Why?
|
Probability | 1 | 2006 | 2470 | 0.010 |
Why?
|
Evidence-Based Medicine | 2 | 2003 | 3647 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2004 | 1979 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 1993 | 17700 | 0.010 |
Why?
|
Protein Precursors | 1 | 2004 | 1125 | 0.010 |
Why?
|
Cost-Benefit Analysis | 2 | 2006 | 5469 | 0.010 |
Why?
|
Prostatic Neoplasms | 2 | 2000 | 11215 | 0.010 |
Why?
|
Sphingomyelins | 1 | 2000 | 103 | 0.010 |
Why?
|
Drug Utilization | 1 | 2006 | 1173 | 0.010 |
Why?
|
Retreatment | 1 | 2001 | 600 | 0.010 |
Why?
|
Luminescent Measurements | 1 | 2001 | 376 | 0.010 |
Why?
|
Monitoring, Intraoperative | 1 | 2005 | 933 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 2001 | 1712 | 0.010 |
Why?
|
Diseases in Twins | 1 | 2000 | 449 | 0.010 |
Why?
|
Treatment Outcome | 3 | 2001 | 63767 | 0.010 |
Why?
|
Drug Costs | 1 | 2006 | 1160 | 0.010 |
Why?
|
United States | 2 | 2012 | 70474 | 0.010 |
Why?
|
Rats | 1 | 1993 | 23700 | 0.010 |
Why?
|
Exercise Test | 1 | 2004 | 2082 | 0.010 |
Why?
|
Pericardium | 1 | 2001 | 666 | 0.010 |
Why?
|
Databases, Factual | 1 | 2012 | 7816 | 0.010 |
Why?
|
User-Computer Interface | 1 | 2003 | 1409 | 0.010 |
Why?
|
Benchmarking | 1 | 2003 | 1029 | 0.010 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2004 | 1602 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2005 | 6228 | 0.010 |
Why?
|
Enzyme Multiplied Immunoassay Technique | 1 | 1995 | 7 | 0.010 |
Why?
|
Treatment Failure | 1 | 2001 | 2616 | 0.010 |
Why?
|
Phenytoin | 1 | 1995 | 189 | 0.010 |
Why?
|
Phenobarbital | 1 | 1995 | 189 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2001 | 3430 | 0.010 |
Why?
|
Carbamazepine | 1 | 1995 | 224 | 0.010 |
Why?
|
Ethambutol | 1 | 1974 | 59 | 0.010 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2001 | 1866 | 0.010 |
Why?
|
Syndrome | 1 | 2000 | 3249 | 0.010 |
Why?
|
Drug Prescriptions | 1 | 2003 | 1645 | 0.010 |
Why?
|
Decision Support Techniques | 1 | 2003 | 1959 | 0.010 |
Why?
|
Valproic Acid | 1 | 1995 | 441 | 0.010 |
Why?
|
Algorithms | 2 | 2004 | 13814 | 0.010 |
Why?
|
Isoniazid | 1 | 1974 | 281 | 0.010 |
Why?
|
Rifampin | 1 | 1974 | 326 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2004 | 5036 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2004 | 4400 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 2000 | 1867 | 0.010 |
Why?
|
Observer Variation | 1 | 1995 | 2578 | 0.010 |
Why?
|
Protein Binding | 1 | 2001 | 9287 | 0.000 |
Why?
|
Pregnancy Complications | 1 | 2000 | 2891 | 0.000 |
Why?
|
Acute Disease | 1 | 1996 | 7125 | 0.000 |
Why?
|
Software | 1 | 1999 | 4401 | 0.000 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2000 | 3911 | 0.000 |
Why?
|
Age Factors | 1 | 2001 | 18159 | 0.000 |
Why?
|
Mass Screening | 1 | 2000 | 5334 | 0.000 |
Why?
|
Drug Therapy, Combination | 1 | 1974 | 6463 | 0.000 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2000 | 10098 | 0.000 |
Why?
|
Health Care Costs | 1 | 1995 | 3194 | 0.000 |
Why?
|
Risk Factors | 2 | 2001 | 72453 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 2007 | 15314 | 0.000 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2000 | 9193 | 0.000 |
Why?
|
Animals | 1 | 1993 | 166578 | 0.000 |
Why?
|
Incidence | 1 | 1996 | 20821 | 0.000 |
Why?
|
Cohort Studies | 1 | 1998 | 40538 | 0.000 |
Why?
|
Adolescent | 1 | 1995 | 86324 | 0.000 |
Why?
|